Industry Committee Expands Scope of National Security Powers and Other ICA Updates
Oct 3, 2023New proposed changes to Investment Canada Act include significant new rules for state-owned enterprises, asset acquisitions, and net-benefit test.
Plan Ahead: CIPO’s new standard fees come into effect on January 1, 2024
Sep 6, 2023CIPO's new standard fees come into effect on January 1, 2024. Plan ahead; save on government fees.
Canadian Patent Law Update: Declarations, Limitation Periods, and General Releases
Aug 1, 2023The Canadian Federal Court reaffirms that limitation periods do not apply to declarations made under Section 52 of the Patent Act.
Net Benefit Reviews Under the Investment Canada Act – Some Practical Thoughts
Jun 6, 2023Glencore plc’s recent approaches to the shareholders of Teck Resources has once again brought the Investment Canada Act into the spotlight.
New Mandatory Reporting Requirement for Businesses: Canada’s Modern Anti-Slavery Bill Becomes Law
May 3, 2023Canada imposes new reporting obligations on forced labour, and what it means for Canadian businesses.
Last Minute Fine Tuning – Québec Government Tries to Soften the Blow of Some of the More Far-Reaching Requirements Under Bill 96, as Applicable to Government Interactions
May 3, 2023Entry into force of the Regulation respecting the language of the civil administration and the Regulation respecting the derogations to the duty of exemplarity
Recent Updates in the Canadian Psychedelics Landscape
Mar 14, 2023Psychedelics have come to be viewed as a potential therapeutic tool by the general public and government. This bulletin summarizes recent Canadian developments.
Government of Alberta to Regulate Health Care Practitioners Administering Psychedelics
Nov 9, 2022Alberta is implementing a new framework for regulating and licensing health care providers in connection with administering psychedelics.
Too Quick to (Summary) Judge: The Shortcomings of Summary Judgment in Patent Actions in Canada
Sep 27, 2022The FCA addresses the shortcomings of summary judgment in patent cases, along with issues relating to "common general knowledge" and experimental testing.
Get updates delivered right to your inbox. You can unsubscribe at any time.